PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells

Autophagy

Volumn 11, Issue 2, 2015, Pages 314-331

  Rah, Bilal ^a,b   ur Rasool, Reyaz ^b   Nayak, Debasis ^b   Yousuf, Syed Khalid ^b   Mukherjee, Debaraj ^b   Kumar, Lekha Dinesh ^c   Goswami, Anindya ^a,b  

^a ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^c CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

3 azido withaferin A; Apoptosis; Autophagy; BCL2; BECN1; PAWR

Indexed keywords

3 AZIDO WITHAFERIN A; BECLIN 1; ENHANCED GREEN FLUORESCENT PROTEIN; MAP1LC3B PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3 BETA; PAWR PROTEIN; PROTEIN BCL 2; REGULATOR PROTEIN; SQSTM1 PROTEIN; UNCLASSIFIED DRUG; WITHAFERIN A; APOPTOSIS REGULATORY PROTEIN; BCL2 PROTEIN, HUMAN; PROSTATE APOPTOSIS RESPONSE-4 PROTEIN; WITHANOLIDE;

APOPTOSIS; ARTICLE; AUTOPHAGY; BIOACCUMULATION; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIZATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; PHARMACOPHORE; PHENOTYPE; PROSTATE CANCER CELL LINE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; DRUG EFFECTS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM STRESS; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; WITHANOLIDES;

EID: 84946903349     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2015.1017182     Document Type: Article

References (65)

1. Amaravadi RK, Lippincott-Schwartz J, Yin X-M, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT, White E. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011; 17:654-66; PMID:21325294; http://dx. doi. org/ 10. 1158/1078-0432. CCR-10-2634
2. Tan SH, Shui G, Zhou J, Li JJE, Bay BH, Wenk MR, Shen HM. Induction of autophagy by palmitic acid via protein kinase c-mediated signaling pathway independent of mTOR (mammalian target of rapamycin). J Biol Chem 2012; 287:14364-76; PMID:22408252; http://dx. doi. org/10. 1074/jbc. M111. 294157
3. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Selfeating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8:741-52; PMID:17717517; http://dx. doi. org/10. 1038/nrm2239
4. Rubinstein AD, Eisenstein M, Ber Y, Bialik S, Kimchi A. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 2011; 44:698-709; PMID:22152474; http://dx. doi. org/10. 1016/j. molcel. 2011. 10. 014
5. Rubinstein AD, Kimchi A. Life in the balance-a mechanistic view of the crosstalk between autophagy and apoptosis. J Cell Sci 2012; 125:5259-68; PMID:23377657; http://dx. doi. org/10. 1242/jcs. 115865
6. Li H, Wang P, Sun Q, Ding W-X, Yin X-M, Sobol RW, Stolz DB, Yu J, Zhang L. Following cytochrome c release, autophagy is inhibited during chemotherapyinduced apoptosis by caspase 8-mediated cleavage of beclin 1. Cancer Res 2011; 71:3625-34; PMID:21444671; http://dx. doi. org/10. 1158/0008-5472. CAN-10-4475
7. Hahm ER, Singh SV. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells. Curr Cancer Drug Targets 2013; 13:640-50; PMID:23607597; http://dx. doi. org/10. 2174/ 15680096113139990039
8. Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2006; 14:500-10; PMID:16990848; http://dx. doi. org/ 10. 1038/sj. cdd. 4402039
9. Rah B, Amin H, Yousuf K, Khan S, Jamwal G, Mukherjee D, Goswami A. A novel MMP-2 inhibitor 3-azido Withaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PloS One 2012; 7:e44039; PMID:22962598; http://dx. doi. org/10. 1371/journal. pone. 0044039
10. Srinivasan S, Ranga RS, Burikhanov R, Han S-S, Chendil D. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res 2007; 67:246-53; PMID:17185378; http://dx. doi. org/10. 1158/0008-5472. CAN-06-2430
11. Pruitt K, Ulku AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Rafindependent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem 2005; 280:23363-70; PMID:15831492; http://dx. doi. org/10. 1074/jbc. M503083200
12. Azmi AS, Ahmad A, Banerjee S, Rangnekar VM, Mohammad RM, Sarkar FH. Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3, 3ʹ Diindolylmethane (DIM). Pharm Res 2008; 25:2117-24; PMID:18427961; http://dx. doi. org/10. 1007/s11095-008-9581-8
13. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, et al. A novel repressor, Par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol 1996; 16:6945-56; PMID:8943350
14. Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem 2003; 278:19995-20005; http://dx. doi. org/10. 1074/jbc. M205865200
15. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7:11-20; PMID:18177721; http://dx. doi. org/10. 1016/ j. cmet. 2007. 10. 002
16. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 2009; 23:537-48; PMID:19270154; http://dx. doi. org/ 10. 1101/gad. 1756509
17. Pattingre S, Levine B. Bcl-2 inhibition of autophagy: a new route to cancer? Cancer Res 2006; 66:2885-8; PMID:16540632; http://dx. doi. org/10. 1158/0008-5472. CAN-05-4412
18. Yuan G, Yan S-F, Xue H, Zhang P, Sun J-T, Li G. Cucurbitacin i induces protective autophagy in glioblastoma in vitro and in vivo. J Biol Chem 2014; 289:10607-19; PMID:24599950; http://dx. doi. org/ 10. 1074/jbc. M113. 528760
19. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007; 6:304-12; PMID:17396135; http://dx. doi. org/10. 1038/nrd2272
20. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120:237-48; PMID:15680329; http://dx. doi. org/10. 1016/j. cell. 2004. 11. 046
21. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10:51-64; PMID:16843265; http:// dx. doi. org/10. 1016/j. ccr. 2006. 06. 001
22. Kim KW, Mutter RW, Cao C, Albert JM, Freeman M, Hallahan DE, Lu B. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem 2006; 281:36883-90; PMID:17005556; http://dx. doi. org/10. 1074/jbc. M607094200
23. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 2008; 68:1485-94; PMID:18316613; http://dx. doi. org/10. 1158/0008-5472. CAN-07-0562
24. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, Gorski SM. Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 2008; 112:389-403; PMID:18172760; http://dx. doi. org/10. 1007/s10549-007-9873-4.
25. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 2009; 16:761-71; PMID:19116755; http://dx. doi. org/10. 1245/s10434-008-0260-0
26. Laussmann MA, Passante E, Düssmann H, Rauen JA, Würstle ML, Delgado ME, Devocelle M, Prehn JH, Rehm M. Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8. Cell Death Differ 2011; 18:1584-97; PMID:21455219; http://dx. doi. org/10. 1038/ cdd. 2011. 27
27. Kim JY, Cho TJ, Woo BH, Choi KU, Lee CH, Ryu MH, Park HR. Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells. Arch Oral Biol 2012; 57:1018-25; PMID:22554995; http:// dx. doi. org/10. 1016/j. archoralbio. 2012. 04. 005
28. Yang SY, Kim NH, Cho YS, Lee H, Kwon HJ. Convallatoxin, a dual inducer of autophagy and apoptosis, inhibits angiogenesis in vitro and in vivo. PLoS One 2014; 9:e91094; PMID:24663328; http://dx. doi. org/ 10. 1371/journal. pone. 0091094
29. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140:313-26; PMID:20144757; http://dx. doi. org/10. 1016/j. cell. 2010. 01. 028
30. Jacobson, MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci 1996; 21:83-6; PMID:8882579; http://dx. doi. org/10. 1016/S0968-0004(96)20008-8
31. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999; 13:1211-33; PMID:10346810
32. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-34; PMID:16148885; http://dx. doi. org/10. 1038/nrc1692
33. Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Ablâ€"mediated drug resistance. Blood 2007; 110:313-22; PMID:17363733; http://dx. doi. org/10. 1182/blood-2006-10-050260
34. Ravikumar B, Rubinsztein DC. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy? Mol Aspects Med 2006; 27:520-7; PMID:16973207; http://dx. doi. org/10. 1016/j. mam. 2006. 08. 008
35. Suzuki SW, Onodera J, Ohsumi Y. Starvation induced cell death in autophagy-defective yeast mutants is caused by mitochondria dysfunction. PLoS One 2011; 6:e17412; PMID:21364763; http://dx. doi. org/ 10. 1371/journal. pone. 0017412
36. Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T, Rangnekar VM. Binding and phosphorylation of Par-4 by Akt is essential for cancer cell survival. Mol Cell 2005; 20:33-44; PMID:16209943; http://dx. doi. org/ 10. 1016/j. molcel. 2005. 08. 016
37. Chendil D, Das A, Dey S, Mohiuddin M, Ahmed MM. Par-4, a pro-apoptotic gene, inhibits radiationinduced NF-kB activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3. Cancer Biol Ther 2002; 1:152-60; PMID:12170775; http://dx. doi. org/10. 4161/cbt. 61
38. Marquez RT, Xu L. Bcl-2: Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res 2012; 2:214; PMID:22485198
39. Nalca A, Qiu SG, El-Guendy N, Krishnan S, Rangnekar VM. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J Biol Chem 1999; 274:29976-83; PMID:10514481; http://dx. doi. org/10. 1074/jbc. 274. 42. 29976
40. El-Guendy N, Rangnekar VM. Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp Cell Res 2003; 283:51-66
41. Maiuri MC, Le Toumelin GT, Criollo A, Rain J-C, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K, Tavernarakis N, et al. Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1. EMBO J 2007; 26:2527-39; PMID:17446862; http://dx. doi. org/10. 1038/sj. emboj. 7601689
42. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004; 6:1221-8; PMID:15558033; http://dx. doi. org/10. 1038/ncb1192
43. Pan X, Zhang X, Sun H, Zhang J, Yan M, Zhang H. Autophagy inhibition promotes 5-fluorouracil-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLoS One 2013; 8:e56679; PMID:23441212; http://dx. doi. org/ 10. 1371/journal. pone. 0056679
44. Djavaheri-Mergny M, Maiuri MC, Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 2010; 29:1717-9; PMID:20101204; http://dx. doi. org/10. 1038/onc. 2009. 519
45. Luo S, Rubinsztein DC. Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-XL. Cell Death Differ 2010; 17:268-77; PMID:19713971; http://dx. doi. org/10. 1038/cdd. 2009.
46. Wirawan E, Walle LV, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, Roelandt R, De Rycke R, Verspurten J, Declercq W, et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 2010; 1:e18; PMID:21364619; http://dx. doi. org/ 10. 1038/cddis. 2009. 16
47. Tang D, Kang R, Livesey KM, Cheh C-W, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ 3rd, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190:881-92; PMID:20819940; http://dx. doi. org/10. 1083/jcb. 200911078
48. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouysségur J, Mazure NM. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29:2570-81; PMID:19273585; http://dx. doi. org/10. 1128/MCB. 00166-09
49. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-6; PMID:9735050; http://dx. doi. org/10. 1126/science. 281. 5381. 1322
50. Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA, Geneste O, Kroemer G. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-XL. Autophagy 2007; 3:374-6; PMID:17438366; http://dx. doi. org/10. 4161/ auto. 4237
51. Wang, J. Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy 2008; 4:947-8; PMID:18769161; http://dx. doi. org/10. 4161/auto. 6787
52. Boehrer S, Chow KU, Beske F, Kukoc-Zivojnov N, Puccetti E, Ruthardt M, Baum C, Rangnekar VM, Hoelzer D, Mitrou PS, et al. In lymphatic cells Par-4 sensitizes to apoptosis by down-regulating Bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation. Cancer Res 2002; 62:1768-75; PMID:11912153
53. Chakraborty M, Qiu SG, Vasudevan KM, Rangnekar VM. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res 2001; 61:7255-63; PMID:11585763
54. Joshi J, Fernandez-Marcos PJ, Galvez A, Amanchy R, Linares JF, Duran A, Pathrose P, Leitges M, Cañamero M, Collado M, et al. Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis. EMBO J 2008; 27:2181-93; PMID:18650932; http://dx. doi. org/ 10. 1038/emboj. 2008. 149
55. Schonthal AH. Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett 2009; 275:163-9; PMID:18692955; http://dx. doi. org/ 10. 1016/j. canlet. 2008. 07. 05
56. Bernales SN, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 2006; 4: e423; PMID:17132049; http://dx. doi. org/10. 1371/ journal. pbio. 0040423
57. Ding W-X, Ni H-M, Gao W, Hou Y-F, Melan MA, Chen X, Stolz DB, Shao ZM, Yin XM. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem 2007; 282:4702-10; PMID:17135238; http://dx. doi. org/10. 1074/jbc. M609267200
58. Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 2009; 138:377-88; PMID:19632185; http://dx. doi. org/ 10. 1016/j. cell. 2009. 05. 022
59. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania Somnifera leaves. Life Sci 2003; 74:125-32; PMID:14575818; http://dx. doi. org/ 10. 1016/j. lfs. 2003. 07. 007
60. Mishra L-C, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev 2000; 5:334-46; PMID:10956379
61. Liu EY, Ryan KM. Autophagy and cancer: issues we need to digest. J Cell Sci 2012; 125:2349-58; PMID:22641689; http://dx. doi. org/10. 1242/jcs. 093708
62. Alvarez JV, Pan T-C, Ruth J, Feng Y, Zhou A, Pant D, Grimley JS, Wandless TJ, Demichele A; I-SPY 1 TRIAL Investigators, Chodosh LA. Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy. Cancer Cell 2013; 24:30-44; PMID:23770012; http://dx. doi. org/10. 1016/j. ccr. 2013. 05. 007
63. Burikhanov R, Shrestha-Bhattarai T, Hebbar N, Qiu S, Zhao Y, Zambetti GP, Rangnekar VM. Paracrine apoptotic effect of p53 mediated by tumor suppressor Par-4. Cell Rep 2014; 6:271-7; PMID:24412360; http:// dx. doi. org/10. 1016/j. celrep. 2013. 12. 020.
64. Pastorino JG, Chen S-T, Tafani M, Snyder JW, Farber JL. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 1998; 273:7770-5; PMID:9516487; http://dx. doi. org/10. 1074/jbc. 273. 13. 7770
65. Eruslanov E, Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Springer: Advanced Protocols in Oxidative Stress II; 2010:57-72.